BIOCANCELL THERAPEUTICS INC. Retained Earnings
BIOCANCELL THERAPEUTICS INC. had Retained Earnings of -$31.14 million as of 2012-03-31, per its 10-Q filed 2012-05-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2012-05-10
- 2012-03-31: Retained Earnings (Accumulated Deficit) -$31.14M.
- 2011-12-31: Retained Earnings (Accumulated Deficit) -$28.75M.
- 2011-09-30: Retained Earnings (Accumulated Deficit) -$26.75M.
- 2011-06-30: Retained Earnings (Accumulated Deficit) -$25.63M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-03-31 | -$31.14M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$28.75M 10-Q · filed 2012-05-10 |
| 2011-09-30 | -$26.75M 10-Q · filed 2011-11-07 |
| 2011-06-30 | -$25.63M 10-Q/A · filed 2011-08-30 |
| 2010-12-31 | -$22.73M 10-K · filed 2012-03-30 |